Bio-Techne (TECH) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)
Bio-Techne (TECH) Net Income towards Common Stockholders Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Bio-Techne | 11.20 Bn | 10.99 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.37% |
| Dec 31, 2025 | -3.80% |
| Sep 30, 2025 | 2.72% |
| Jun 30, 2025 | -35.26% |
| Mar 31, 2025 | -9.12% |
| Dec 31, 2024 | -21.84% |
| Sep 30, 2024 | 18.47% |
| Jun 30, 2024 | 29.87% |
| Mar 31, 2024 | 1.90% |
| Dec 31, 2023 | 9.36% |
| Sep 30, 2023 | 23.99% |
| Jun 30, 2023 | 81.92% |
| Mar 31, 2023 | 28.89% |
| Dec 31, 2022 | 0.47% |
| Sep 30, 2022 | 41.42% |
| Jun 30, 2022 | 95.04% |
| Mar 31, 2022 | 22.09% |
| Dec 31, 2021 | 57.37% |
| Sep 30, 2021 | 29.63% |
| Jun 30, 2021 | -20.82% |